Induction of humoral and cellular responses in cynomolgus monkeys immunised with mannan-human MUC1 conjugates

Vaccine

Volumn 17, Issue 20-21, 1999, Pages 2740-2752

  Vaughan, Hilary A ^a   Ho, Deborah W M ^a   Karanikas, Vaios A ^a   Ong, Chin Swee ^a   Hwang, Le Ann ^a   Pearson, Julian M ^a   McKenzie, Ian F C ^a   Pietersz, Geoffrey A ^a  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

Author keywords

Breast cancer; Macaque; Mannan; MUC1; Vaccine

Indexed keywords

MANNAN; MUCIN;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG CONJUGATION; HUMORAL IMMUNITY; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MACACA; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY FORMATION; CA-15-3 ANTIGEN; CYCLOPHOSPHAMIDE; DISACCHARIDES; EPITOPE MAPPING; HUMANS; IMMUNIZATION; LYMPHOCYTE ACTIVATION; MACACA FASCICULARIS; MANNANS; MICE; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTES, CYTOTOXIC; TETANUS TOXOID; VACCINES, CONJUGATE;

EID: 0033522823     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00493-9     Document Type: Article

References (38)

1. Boon T., Cerottini J.-C., Van den Eynde B., Van den Bruggen P., Van Pel A. Tumor antigen recognised by T-lymphocytes. Ann Rev Immunol. 12:1994;337-365.
2. Apostolopoulos V., McKenzie I.F.C. Cellular mucins: targets for immunotherapy. Crit Rev Immunol. 14:1994;293-309.
3. Finn O.J., Jerome K.R., Henderson R.A., Pecher G., Domenech N., Magarian-Blander J., Barret-Boyes S.M. MUC-1 epithelial tumour mucin-based immunity and cancer vaccines. Immun Rev. 154:1995;61-89.
4. Gendler S.J., Spicer A.P. Epithelial mucin genes. Annu Rev Physiol. 57:1995;607-634.
5. Gendler S.J., Burchell J.M., Duhig T., Lamport D., White R., Parker M., Taylor-Papadimitriou J. Cloning of partial cDNA coding differentiation and tumor associated mucin glycoproteins expressed by human mammary epithelium. Proc Natl Acad Sci USA. 84:1987;6060-6064.
6. Gendler S.J., Taylor-Papadimitriou J., Duhig T., Rothbard J., Burchell J. A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made of tandem repeats. J Biol Chem. 263:1988;12820-12823.
7. Gendler S.J., Lancaster C.A., Taylor-Papadimitriou J., Duhig T., Burchell J., Pemberton L., Lalani E.-N., Wilson D. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem. 265:1990;15286-15293.
8. Siddiqui J., Abe M., Hayes E., Yunis E., Kufe D. Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc Natl Acad Sci USA. 85:1987;2320-2323.
9. Hareuveni M., Tsarfaty I., Zaretsky J., Kotkes P., Horev J., Zrihan S., Weiss M., Green S., Lathe R., Keydar I., Wreschner D.H. A transcribed gene, containing a variable number of tandem repeats, codes for a human epithelial tumour antigen. Eur J Biochem. 189:1990;475-486.
10. Lightenberg M.J.L., Vos H.L., Gennissen A.M.C., Hilkens J. Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variants with amino termini. J Biol Chem. 265:1990;5573-5578.
11. Xing P.-X., Reynolds K., Tjandra J.J., Tang X.-L., McKenzie I.F.C. Synthetic peptides reactive with anti-human milk fat globule membrane monoclonal antibodies. Cancer Res. 50:1990;89-96.
12. Rughetti A., Turchi V., Ghetti C.A., Scambia G., Panici P.B., Ronucci G., Mancuso S., Fratti L., Nutti M. Human B-cell immune response to the polymorphic epithelial mucin. Cancer Res. 53:1993;2457-2459.
13. Kotera Y., Fontenot J.D., Pecher G., Metzgar R.S., Finn O.J. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic and colon cancer patients. Cancer Res. 54:1994;2856-2860.
14. Barnd D.L., Lan M.S., Metzgar R.S., Finn O.J. Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T-cells. Proc Natl Acad Sci USA. 86:1989;7159-7163.
15. Jerome K.R., Barnd D.L., Bendt K.M., Boyer C.M., Taylor-Papadimitriou J., McKenzie I.F.C., Bast R.C. Jr., Finn O.J. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognise an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res. 51:1991;2908-2916.
16. Jerome K.R., Domenech N., Finn O.J. Tumor-specific cytotoxic T-cell clones from patients with breast and pancreatic adenocarcinoma recognise EBV-immortalised B-cells transfected with polymorphic epithelial mucin complementary DNA. J Immunol. 151:1993;1654-1662.
17. Ioaniddes C.G., Fisk B., Jerome K.R., Irmura T., Wharton T.J., Finn O.J. Cytotoxic T-cells from ovarian malignant tumors can recognise polymorphic epithelial mucin core peptides. J Immunol. 151:1994;3693-3703.
18. Takahashi T., Makiguchi Y., Hinoda Y., Kakiuchi H., Nakagawa N., Imai K., Yachi A. Expression of MUC1 on myeloma cells and induction of HLA unrestricted CTL against MUC1 from a multiple myeloma patient. J Immunol. 153:1994;2102-2109.
19. Domenech N., Henderson R.A., Finn O.J. Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumour antigen mucin. J Immunol. 155:1995;4766-4774.
20. Bohm C.M., Mulder M.C., Zennadi R., Notter M., Schmitt-Graff A., Finn O.J., Taylor-Papadimitriou J., Stein H., Clausen H., Riecken E.O., Hanski C. Carbohydrate recognition on MUC1-expressing targets enhances cytotoxicity of a T-cell subpopulation. Scand J Immunol. 46:1997;27-34.
21. 2 responses. Proc Natl Acad Sci USA. 92:1995;10128-10132.
22. Apostolopoulos V., Pietersz G.A., McKenzie I.F.C. Cell-mediated immune responses to MUC1 fusion protein coupled to mannan. Vaccine. 14:1996;930-938.
23. Kennedy R.C., Shearer M.H., Hildebrand W. Nonhuman primate models to evaluate vaccine safety and immunogenicity. Vaccine. 15:1997;903-908.
24. Spicer A.P., Parry G., Patton S., Gendler S.J. Molecular cloning and analysis of the mouse homologue of the tumor-associated mucin, MUC1, reveals conservation of potential O-glycosylation sites, transmembrane, and cytoplasmic domains and a loss of minisatellite-like polymorphism. J Biol Chem. 206:1991;15099-15109.
25. Vos H.L., de Vries Y., Hilkens J. The mouse episialin (MUC1) gene and its promoter. Biochem Biophys Res Commun. 181:1991;121-130.
26. Apostolopoulos V., Popovski V., McKenzie I.F.C. Cyclophosphamide enhances the CTL precursor frequency in mice immunized with MUC1-mannan fusion protein (M-FP). J Immunother. 21:1997;109-113.
27. + cytotoxic T-lymphocytes in rhesus monkeys. J Immunol. 151:1993;5096-5105.
28. National Health and Medical Research Council Commonwealth Scientific and Industrial Research Organisation Australian Agricultural Council. Australian code of practise for the care and use of animals for scientific purposes. 1990;Australian Government Publishing Service Canberra.
29. Vaughan H.A., Oldenburg K.R., Gallop M.A., Atkin J.D., McKenzie I.F.C. Recognition of an octapeptide sequence by multiple Galα(1,3)Gal-binding proteins. Xenotransplantation. 3:1996;18-23.
30. Karanikas V., Hwang L., Pearson J., Ong C.-S., Apostolopoulos V., Vaughan H.A., Xing P.-X., Jamieson G., Pietersz G.A., Tait B.D., Broadbent R., Thynne G., McKenzie I.F.C. Antibody and T-cell responses of patients with adenocarcinoma immunised with mannan-MUC1 fusion protein. J Clin Invest. 100:1997;2783-2792.
31. Pietersz G.A., Li W., Popovski V., Caruana J.A., Apostolopoulos V., McKenzie I.F.C. Parameters for using mannan-MUC1 fusion protein (MFP) to induce cellular immunity. Cancer Immunol Immunother. 45:1998;321-326.
32. Xing P.-X., Prenzoska J., Quelch K., McKenzie I.F.C. Second generation anti-MUC1 peptide monoclonal antibodies. Cancer Res. 52:1992;2310-2317.
33. Xing P.-X., Prenzoska J., McKenzie I.F.C. Epitope mapping of anti-breast and anti-ovarian mucin monoclonal antibodies. Mol Immunol. 29:1992;641-650.
34. Nakao M., Yamana H., Imai Y., Toh Y., Toh U., Kimura A., Yanoma S., Kakegawa T., Itoh K. HLA A2601-restricted CTL's recognise a peptide anigen expressed on squamous cell carcinoma. Cancer Res. 55:1995;4248-4252.
35. Ressing M.E., van Driel W.J., Celis E., Sette A., Brandt M., Hartman M., Anholts J.D.H., Schreuder G.M.T., Bram Ter Harmsel W., Jan Fleuren G., Trimbos B.J., Kast W.M., Melief C.J.M. Occasional memory cytotoxic T-cell responses of patients with papilloma virus type 16-positive cervical lesions against a human leukocyte antigen-A*0201-restricted E7-encoded epitope. Cancer Res. 56:1996;582-588.
36. Pecher G., Finn O. Induction of cellular immunity in chimpanzees to human tumor-associated antigen mucin by vaccination with MUC-1 cDNA-transfected Epstein-Barr virus-immortalized autologous B-cells. Proc Natl Acad Sci USA. 93:1996;1699-1704.
37. Apostolopoulos V., Osinski C., McKenzie I.F.C. MUC1 cross-reactive Galα(1,3)Gal antibodies in humans switch immune responses from cellular to humoral. Nat Med. 4:1998;315-320.
38. Galilli U., Clark M.R., Shohet S.B., Buehler J., Macher B.A. Evolutionary relationship between the natural anti-Gal antibody and the Galα1-3Gal epitope in primates. Proc Natl Acad Sci USA. 84:1987;1369-1373.